Abstract:This review emphatically focusses on a comprehensive summary of the molecular design strategies of advanced organic semiconducting agents emitting in the second near‐infrared window (NIR‐II) for improving the properties of NIR‐II photonics and optimizing disease phototheranostics. By summarizing the current research progress, this review may shed light on organic semiconducting nanoplatforms for improving precise theranostics, while providing continuous breakthrough toward clinical transformation. Second near‐infrared window (NIR‐II, 1000−1700 nm) fluorescence imaging (FI) in phototheranostics benefits from deep tissue penetration, negligible body spontaneous fluorescence, exceptional spatiotemporal resolution, and diversified imaging agents. Inorganic and metal nanomaterials with NIR‐II emission are widely explored for NIR‐II FI, however, the concern about their intrinsic long‐term toxicity hampers further clinic applications. By contrast, whole organic NIR‐II FI agents, in particular, organic semiconducting molecules derived from large π‐conjugated molecular architectures and biologically amicable ingredients, owning inert photophysical potencies, tunable optical properties, and favorable biocompatibility, have the potential to be degraded and excreted from the body in molecular level. In this review, the development of NIR‐II fluorescence‐emitting organic semiconducting nanoplatforms, with a focus on their theranostic applications in biomedicine is discussed. The recent advances in the molecular design of semiconducting NIR‐II emitting agents for improving the properties of NIR‐II photonics (e.g., emission intensity, quantum yield, emission wavelength, and activatable emission) and optimizing disease phototheranostics (the synergistic combination of NIR‐II FI‐based diagnosis and photo‐related therapeutic methods) are highlighted. Finally, the challenges and perspectives to building high‐powered new‐generation organic semiconducting nanoplatforms for NIR‐II phototheranostics of a variety of diseases are discussed.

Bio‐Erasable Intermolecular Donor–Acceptor Interaction of Organic Semiconducting Nanoprobes for Activatable NIR‐II Fluorescence Imaging

Synchronously Manipulating Absorption and Nonradiative Transition of Croconaine Via Donor Engineering for Efficient NIR-II Photothermal Theranostics

Donor Engineering for NIR-II Molecular Fluorophores with Enhanced Fluorescent Performance

Recent Advances in Activatable NIR-II Organic Fluorophores for Biomedical Applications

A General Strategy for Development of Activatable NIR‐II Fluorescent Probes for in Vivo High‐Contrast Bioimaging

Acceptor engineering of semiconducting oligomers for improved NIR-II fluorescence imaging and therapy

Preparation of NIR-II Polymer Nanoprobe Through Twisted Intramolecular Charge Transfer and Förster Resonance Energy Transfer of NIR-I Dye

Recent Advances on Activatable NIR‐II Fluorescence Probes for Biomedical Imaging

NIR-II Emissive Donor-Acceptor-Donor Fluorophores for Dual Fluorescence Bioimaging and Photothermal Therapy Applications

A<sub>2</sub>O<sub>2</sub>-activatable nanoprobe for diagnosing interstitial cystitis and liver ischemia-reperfusion injury via multispectral optoacoustic tomography and NIR-II fluorescent imaging

Propylenedioxy Thiophene Donor to Achieve NIR-II Molecular Fluorophores with Enhanced Brightness

A “donor–acceptor” Structured Semiconductor Polymer for Near Infrared Fluorescence Imaging Guided Photodynamic Therapy

Activatable NIR‐II Fluorescent Probes Applied in Biomedicine: Progress and Perspectives

Antiaggregation of NIR-II Probe Regulated by Amphiphilic Polypeptide with High Contrast Brightness for Phototheranostics and Vascular Microscopic Imaging under 1064 nm Irradiation

NIR-II Cell Endocytosis-Activated Fluorescent Probes for in Vivo High-Contrast Bioimaging Diagnostics.

Engineering of Cyanine-Based Nanoplatform with Tunable Response Toward Reactive Species for Ratiometric NIR-II Fluorescent Imaging in Mice.

Activatable Second Near-Infrared Fluorescent Probes: A New Accurate Diagnosis Strategy for Diseases.

A H 2 O 2 -activatable nanoprobe for diagnosing interstitial cystitis and liver ischemia-reperfusion injury via multispectral optoacoustic tomography and NIR-II fluorescent imaging

Rational Molecular Engineering of Organic Semiconducting Nanoplatforms for Advancing NIR‐II Fluorescence Theranostics

Promoting the Near-Infrared-ii Fluorescence of Diketopyrrolopyrrole-Based Dye for in Vivo Imaging Via Donor Engineering

Er3+ Self-Sensitized Nanoprobes with Enhanced 1525 Nm Downshifting Emission for NIR-IIb in Vivo Bio-Imaging